This is a mobile optimized page that loads fast, if you want to load the real page, click this text.

UBI - Universal Biosensors

Last edited:
In vino veritas?

UBI’s wine analytical test platform, Sentia. ... made first sales of its Sentia device and free SO2 test strips to companies operating in France, Italy, Germany, Spain, Portugal and Switzerland.
Verily, ad astra.

UBI continues its bullish run.


gg
 
It doesn't seem to have the oomph atm or as we say in Gaul montre-moi du pèze.

Show patience or move on ??

gg
Haven't looked at FA on this since it was around 15 cent.
I remember I liked the potential of the tech and market involved, but just never bought.

On a medium to long term basis, it's probably still a goer, however on a short term basis, the next week or 2 will be telling.

One would want to see it bouncing off current resistance and trend lines area as per @aus_trader chart, so around that 81 cent level.

Would be interested on what the wave guys predict, my guess on that front would be a break down past resistance to low/mid 70's before resuming up trend, just a guess though.
(Have decided I should look into the Elliot wave business a bit, an indicator that I haven't used).

There's one opinion for ye.

Edit; was just thinking outside the box and tech and health index's have had good runs, probably some chart correlation there and one might want to look at those index's when forming an opinion. (XHJ and XTX)

 
Last edited:
the big one

and today
The trial is scheduled to commence during October and results should be available during Q1 2022.
the Timeline goes out to 2024 before the Regulatory boxes are ticked.

... and creeping back up to the July highs
 
Goes beyond a distribution agreement, Vivelys wants in on sensor development for other wine testing factors. Not closely followed but I get the impression that UBI is sewing the French wine industry up.
"With its ability to measure free SO2 simply and immediately, and soon sugars and malic acid, Sentia strengthens Vivelys' solutions"
Won't be buying myself, it's a possible crash investment should it happen, as long as it isn't cash poor.



 
Holy smoke, just came across this. What the hell happened? I came very close to buying a first tranche of this before this crash. I have it on a watchlist but hadn't twigged to the plunge at all. I suppose I should read latest announcements b4 posting but can't be bothered tonight. What could do this to a biotech with such alluring technology?
Not Held.

Daily
 
So that's another $20m that UBI gets from the underwriting of the entitlement offer.
My understanding - the underwriter will pay 0.77 despite current share price of around 0.47

 
Viburnum Funds came through with its underwriting commitment and swallowed almost the entire entitlement offer @ 0.77 for $19.9m, whereas even today, upon the announcement of $25.2m banked cash, the share price is only 0.465. Rest of the $25.2m + fees came from a smaller placement.

 
@finicky @frugal.rock

I was burnt by this mob buying at 80c from memory and selling at 60c.

To paraphrase Plautus.

Est etiam, ubi profecto damnum praestet facere, quam spe lucri.

Perhaps they will rise like the phoenix.

gg
 
Cookies are required to use this site. You must accept them to continue using the site. Learn more...